Johnson & Johnson’s Kenvue valued at around $41 billion in IPO

By Julia Wray | Published: 4-May-2023

The health care giant’s new consumer health arm priced above the middle of the expected range ahead of trading on the New York Stock Exchange

Johnson & Johnson’s Kenvue consumer health business has been valued at around US$41bn in its initial public offering.

The company announced it will list 172,812,560 shares at a price of $22 per share, slightly above the middle of its price range.

Read more:

Johnson & Johnson readies IPO for Kenvue consumer health business

It had earlier announced its intention to sell shares at a range between $20 and $23 per share.

The stock will begin trading on the New York Stock Exchange under the symbol KVUE today.

J&J will continue to own more than 90% of Kenvue’s shares.

The deal is said to be the largest IPO pan-industry to launch since electric vehicle maker Rivian Automotive listed its shares on Nasdaq in late 2021.

  • Companies:
  • Johnson and Johnson
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Skin Care

J&J recalls Clean & Clear Facial Cleansers in the US due to micro contamination

Read more
An FDA enforcement report notice states the company is voluntarily recalling at wholesale level 7,800 bottles of Clean & Clear’s Morning Burst Facial Cleanser

Trending Articles

  1. Neutrogena lays off staff as it closes Los Angeles office Neutrogena’s parent company Kenvue is consolidating its operations in New Jersey
  2. Colgate-Palmolive and P&G lag behind Unilever at cutting back emissions A study by Planet Tracker found some FMCG companies’ emissions were seven times higher than the recommended level
  3. Beiersdorf opens 'agile working' campus in Hamburg The 51,000sqm space includes a newly-built corporate headquarters
  4. Nivea helps push Beiersdorf sales to €4.9 billion in H1 Sun protection was pinpointed as a strong performance segment for the German giant's Nivea, Eucerin and Aquaphor brands
  5. Sephora reveals opening date for Manchester store The luxury beauty retailer’s third UK location at the Trafford Centre is opening sooner than you think

Upcoming event

Cosmetic Product Safety Assessment E-Training: Starting the Assessment

19 April 2024 | Virtual See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Skin Care

J&J recalls Clean & Clear Facial Cleansers in the US due to micro contamination

An FDA enforcement report notice states the company is voluntarily recalling at wholesale level 7,800 bottles of Clean & Clear’s Morning Burst Facial Cleanser
Skin Care

Neutrogena signs Olympic gold medalist Sydney McLaughlin-Levrone as ambassador

The US track star will represent the skin care brand alongside existing ambassadors Jenna Ortega and Chloe and Halle Bailey
Skin Care

J&J to hold 9.5% stake in consumer health spinoff Kenvue following share exchange

The multinational launched the exchange offer in July in a bid to take its hands off the Kenvue reins
Regulatory

Johnson & Johnson to appeal $19 million owed to California cancer patient

The talc cancer trial involving 24-year-old Emory Hernandez Valadez was the first faced by J&J since its bankruptcy filing
You need to be a subscriber to read this article.
Click here to find out more.
Colour Cosmetics

Metaverse Beauty Week day 4 review - madcap mushrooms and nonsensical buildings shadow over potential

The Cosmetics Business editorial team will be reviewing each day of Metaverse Beauty Week 2023, 12-17 June
Regulatory

Johnson & Johnson faces first new talc cancer trial since bankruptcy filing

Judge overseeing LTL Management’s Chapter 11 has allowed the trial to go ahead, as 24-year-old cancer patient Anthony Hernandez Valadez does not have long to live
You need to be a subscriber to read this article.
Click here to find out more.
Sustainability

Top 50 beauty brands 2023: Which is the world’s biggest brand?

L’Oréal has retained its status as the world’s most valuable beauty brand on Brand Finance’s league table, but did its value rise or dive in 2023?
Subscribe now